1. Home
  2. UVE vs EVO Comparison

UVE vs EVO Comparison

Compare UVE & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UNIVERSAL INSURANCE HOLDINGS INC

UVE

UNIVERSAL INSURANCE HOLDINGS INC

N/A

Current Price

$34.86

Market Cap

925.9M

Sector

Finance

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$2.35

Market Cap

821.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UVE
EVO
Founded
1990
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
925.9M
821.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
UVE
EVO
Price
$34.86
$2.35
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$40.00
$7.00
AVG Volume (30 Days)
199.0K
110.0K
Earning Date
04-23-2026
05-05-2026
Dividend Yield
2.32%
N/A
EPS Growth
214.43
N/A
EPS
6.32
N/A
Revenue
$1,603,915,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.88
$7.13
P/E Ratio
$5.24
N/A
Revenue Growth
5.48
N/A
52 Week Low
$20.83
$2.31
52 Week High
$36.68
$4.80

Technical Indicators

Market Signals
Indicator
UVE
EVO
Relative Strength Index (RSI) 58.11 27.69
Support Level $30.42 $2.31
Resistance Level $35.62 $3.78
Average True Range (ATR) 0.94 0.08
MACD -0.16 -0.02
Stochastic Oscillator 59.19 6.03

Price Performance

Historical Comparison
UVE
EVO

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: